Cite
HARVARD Citation
Wang, W. et al. (2020). Efficacy and safety of DBPR108 monotherapy in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled, phase II clinical trial. Current medical research and opinion. pp. 1107-1115. [Online].